Clinical Trials Directory

Trials / Unknown

UnknownNCT05607368

Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Tryptase, TLR4, and anti-NR2A antibodies were measured in serum, cerebrospinal fluid, and subjects and other markers to assess their relevance to disease activity, aiming to find new therapeutic targets,Timely intervention to improve the prognosis of SLE and improve the quality of life of patients with SLE.

Detailed description

This study is a prospective cohort study: it is proposed to be divided into 3 groups, namely healthy control group and SLE group, NPSLE epilepsy group; Fifteen cases were included in each group, with the consent of the subjects and signed to know Consent form, record all subjects' clinical and laboratory test data, and test subjects' blood. Markers such as cerebrospinal fluid tryptase, TLR4 and anti-NR2A antibodies, follow-up 2 year, the patient's disease activity is evaluated every year, the change of indicators is dynamically observed, and statistical points are made divide.

Conditions

Timeline

Start date
2022-01-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2022-11-07
Last updated
2022-11-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05607368. Inclusion in this directory is not an endorsement.

Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy (NCT05607368) · Clinical Trials Directory